Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab
Naresh Gupta(Hagerstown Community College), Vijay H. Shah(Mayo Clinic in Arizona), Tulika Seth(Manipal Academy of Higher Education), M. Joseph John(The University of Texas Health Science Center at Houston), Cecil Ross(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Sunita Aggarwal(Maulana Azad Medical College), Varun Kaul(Guru Gobind Singh Medical College and Hospital), Nita Radhakrishnan, Anupam Datta(ATUM (United States)), Chandrakala Shanmukhaiah, Bilal Ahmed(Government Medical College), Gerard Dolan(Bournemouth University)
Cited by 9
Related Papers
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
|JAMA|2017|668
MELD accurately predicts mortality in patients with alcoholic hepatitis†
|Hepatology|2005|530
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates
|Gastroenterology|2008|306
ACG Clinical Guideline: Alcohol-Associated Liver Disease
|The American Journal of Gastroenterology|2023|227